Private Market View

CytoTronics

Boston, MA · Founded 2020 · Privately Held (backing)

Last price · $/share
Implied valuation
$39.0M
Total raised
$22.8M
Last round
Early Stage VC
Mar 2024
What is CytoTronics worth?
$39.0Mlast known valuation

CytoTronics last raised $13.5M in its Early Stage VC (Mar 2024).

Free account
See the evidence behind this price
  • ·Post-money valuations for all 1 rounds
  • ·The complete investor list — 9 names
  • ·Watchlist + deal alerts for CytoTronics
Create free account
No card required

Funding history

1 rounds
DateRoundRaisedPost-money
Mar 2024Early Stage VC$13.5M

How CytoTronics's valuation is determined

Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.

For CytoTronics, too few pricing signals exist to publish a composite mark; the figures above reflect the most recent observed valuation event. Full methodology →

Frequently asked

What is CytoTronics worth?
CytoTronics's last known valuation is $39.0M.
How much has CytoTronics raised?
CytoTronics has raised $22.8M in total funding across 1 recorded rounds.
When did CytoTronics last raise?
CytoTronics last raised in Mar 2024 (Early Stage VC), raising $13.5M.